Siglecs in innate immunity

被引：176

作者：

Crocker, PR ^{[1
]}

机构：

[1] Univ Dundee, Wellcome Trust Bioctr, Div Cell Biol & Immunol, Dundee DD1 5EH, Scotland

来源：

CURRENT OPINION IN PHARMACOLOGY | 2005年 / 5卷 / 04期

基金：

英国惠康基金;

关键词：

D O I：

10.1016/j.coph.2005.03.003

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Siglecs are sialic acid-binding Ig-like lectins expressed in a highly specific manner, and which are implicated in signaling and adhesive functions. The CD33-related siglecs represent a distinct subgroup that is undergoing rapid evolution within the innate immune system, with the potential to trigger apoptosis and provide inhibitory signals. CD22 is a well-characterised B cell restricted siglec that has been shown to mediate both sialic acid-dependent and independent signaling functions in B cell regulation. As endocytic receptors, siglecs provide portals of entry for certain viral and bacterial pathogens, as well as therapeutic opportunities for targeting innate immune cells in disease.

引用

页码：431 / 437

页数：7

共 52 条

[1] High resolution crystal structures of Siglec-7 - Insights into ligand specificity in the Siglec family
Alphey, MS
Attrill, H
Crocker, PR
van Aalten, DMF
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (05) : 3372 - 3377
[2] Large-scale sequencing of the CD33-related Siglec gene cluster in five mammalian species reveals rapid evolution by multiple mechanisms
Angata, T
Margulies, EH
Green, ED
Varki, A
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (36) : 13251 - 13256
[3] The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by siglecs-7 and-9, CD33-related Siglecs expressed on human monocytes and NK cells
Avril, T
Floyd, H
Lopez, F
Vivier, E
Crocker, PR
[J]. JOURNAL OF IMMUNOLOGY, 2004, 173 (11) : 6841 - 6849
[4] Siglec-5 (CD170) can mediate inhibitory signaling in the absence of immunoreceptor tyrosine-based inhibitory motif phosphorylation
Avril, T
Freeman, SD
Attrill, H
Clarke, RG
Crocker, PR
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (20) : 19843 - 19851
[5] Anti-CD33 monoclonal antibodies enhance the cytotoxic effects of cytosine arabinoside and idarubicin on acute myeloid leukemia cells through similarities in their signaling pathways
Balaian, L
Ball, ED
[J]. EXPERIMENTAL HEMATOLOGY, 2005, 33 (02) : 199 - 211
[6] The inhibitory effect of anti-CD33 monoclonal antibodies on AML cell growth correlates with Syk and/or ZAP-70 expression
Balaian, L
Zhong, RK
Ball, ED
[J]. EXPERIMENTAL HEMATOLOGY, 2003, 31 (05) : 363 - 371
[7] Printed covalent glycan array for ligand profiling of diverse glycan binding proteins
Blixt, O
Head, S
Mondala, T
Scanlan, C
Huflejt, ME
Alvarez, R
Bryan, MC
Fazio, F
Calarese, D
Stevens, J
Razi, N
Stevens, DJ
Skehel, JJ
van Die, I
Burton, DR
Wilson, IA
Cummings, R
Bovin, N
Wong, CH
Paulson, JC
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (49) : 17033 - 17038
[8] Glycan array screening reveals a candidate ligand for Siglec-8
Bochner, BS
Alvarez, RA
Mehta, P
Bovin, NV
Blixt, O
White, JR
Schnaar, RL
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (06) : 4307 - 4312
[9] Signals for sorting of transmembrane proteins to endosomes and lysosomes
Bonifacino, JS
Traub, LM
[J]. ANNUAL REVIEW OF BIOCHEMISTRY, 2003, 72 : 395 - 447
[10] CD33/Siglec-3 binding specificity, expression pattern, and consequences of gene deletion in mice
Brinkman-Vand der Linden, ECM
Angata, T
Reynolds, SA
Powell, LD
Hedrick, SM
Varki, A
[J]. MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (12) : 4199 - 4206

← 1 2 3 4 5 6 →